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Abstract
Background: PDZ domains mediate protein-protein interactions involved in important biological processes
through the recognition of short linear motifs in their target proteins. Two recent independent studies have used
protein microarray or phage display technology to detect PDZ domain interactions with peptide ligands on a large
scale. Several computational predictors of PDZ domain interactions have been developed, however they are
trained using only protein microarray data and focus on limited subsets of PDZ domains. An accurate predictor of
genomic PDZ domain interactions would allow the proteomes of organisms to be scanned for potential binders.
Such an application would require an accurate and precise predictor to avoid generating too many false positive
hits given the large amount of possible interactors in a given proteome. Once validated these predictions will help
to increase the coverage of current PDZ domain interaction networks and further our understanding of the roles
that PDZ domains play in a variety of biological processes.
Results: We developed a PDZ domain interaction predictor using a support vector machine (SVM) trained with
both protein microarray and phage display data. In order to use the phage display data for training, which only
contains positive interactions, we developed a method to generate artificial negative interactions. Using cross-
validation and a series of independent tests, we showed that our SVM successfully predicts interactions in different
organisms. We then used the SVM to scan the proteomes of human, worm and fly to predict binders for several
PDZ domains. Predictions were validated using known genomic interactions and published protein microarray
experiments. Based on our results, new protein interactions potentially associated with Usher and Bardet-Biedl
syndromes were predicted. A comparison of performance measures (F1 measure and FPR) for the SVM and
published predictors demonstrated our SVM’s improved accuracy and precision at proteome scanning.
Conclusions: We built an SVM using mouse and human experimental training data to predict PDZ domain
interactions. We showed that it correctly predicts known interactions from proteomes of different organisms and is
more accurate and precise at proteome scanning compared with published state-of-the-art predictors.
Background
Many protein-protein interactions in eukaryotic signal-
ling systems are mediated by conserved modular protein
recognition domains, which are organized in different
ways to form larger proteins. The PSD95/DlgA/Zo-1
(PDZ) domain is a protein recognition domain that is
found in increasing abundance in yeast to metazoans
with 250 encoded in the human genome [1]. They are
often found in scaffolding proteins and interact with ion
channels, adhesion molecules, and neurotransmitter
receptors in signalling proteins to maintain cell polarity,
facilitate signal coupling and regulate synaptic develop-
ment [2]. Furthermore, studies have shown that the dis-
ruption of PDZ domain mediated interactions are
associated with diseases such as human papillomavirus,
cystic fibrosis and schizophrenia [3-5].
The PDZ domain consists of 80-90 amino acid residues
folded into five to six b strands and two a helices. Canoni-
cal interactions occur through the recognition of hydro-
phobic C terminal tails of target proteins binding in a
groove formed between strand b2 and helix a2. Early stu-
dies grouped PDZ binding specificity into two classes
focusing on residues at position 0 and -2 of the ligand [6]
(position numbering counted backwards from the 0 C
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PDZ binding pocket can interact with, and is highly speci-
fic to, as many as seven target C terminal residues
enabling the recognition of a diverse set of ligands [7,8].
A wealth of knowledge about PDZ domain interactions is
now available from various sources. Some focus on select
family members while recent high throughput experiments
study many domains from across the entire family [7-9].
The biological importance of PDZ domains, their simple
modes of target recognition and the availability of experi-
mentally determined interactions have prompted the
development of PDZ domain interaction prediction meth-
ods by multiple groups. Such methods are based on estab-
lished techniques, which have been used with success to
predict interactions for SH2 and SH3 domains, protein
serine-threonine kinases and major histocompatibility
complex (MHC) molecules [10-14]. Position weight
matrices (PWMs) contain in each cell the probability of
observing an amino acid at a given ligand position and are
commonly used to compute a score describing the binding
preference of a PDZ domain for a given peptide. Tonikian
et al., used PWMs to predict human PDZ interactions and
identify viral proteins that mimicked domain specificities
[7]. Stiffler et al., developed a variant of the PWM that
contained weights describing the relative preference for
amino acids at positions in the ligand compared to the
other domains they modelled [9]. Another method by Eo
et al. used a machine learning method called a support
vector machine (SVM) to predict PDZ domain interac-
tions, though limited to those involving G coupled pro-
teins [15]. While these methods can predict PDZ domain
interactions, their common limitation is that they were
trained to ideally predict interactions for specific or limited
subsets of PDZ domains. Recently, Chen et al., used an
additive model to predict interactions for the entire PDZ
domain family using data from Stiffler et al. [16]. They
also demonstrated the predictor’s ability to predict mouse
genomic interactions and to a lesser extent genomic inter-
actions in other organisms. This predictor was validated
on a limited data set, thus it is not clear if it can be used
to accurately and precisely predict interactions given a
large set of possible interactors.
A practical application of a reliable PDZ domain inter-
action predictor would be to use it to scan the proteomes
of organisms for potential binders of PDZ domains. The
results would help direct future experiments to increase
the coverage of current PDZ domain interaction net-
works and expand our knowledge of the roles that PDZ
domains play in different biological processes. In this
paper we present a primary sequence based predictor of
genomic interactions involving PDZ domain family mem-
bers using a SVM. Unlike published predictors, our SVM
is trained using data from two independent high
throughput studies using protein microarray and phage
display technologies, which makes it more general. Since
the phage display data consists of only positive interac-
tions, we have overcome a major issue, which has up to
now prevented its straightforward use for predictor train-
ing. We addressed this by developing a method for the
generation of artificial negative interactions from data
consisting of positive interactions only. This method gen-
erates more biologically meaningful negatives compared
to other commonly used methods that use randomization
or shuffling. Through independent testing with published
genomic data sets, we showed the SVM’s ability to accu-
rately predict interactions in multiple organisms [16].
We then used the SVM to scan human, worm and
fly proteomes to predict binders for different PDZ
domains. We validated the predictions using known
genomic interactions from PDZBase and protein micro-
array experiments [16,17]. Finally a comparison of pro-
teome scanning performance, which depends on
minimizing the number of false positives generated,
showed the SVM’s improved accuracy and precision
compared to published predictors. Predicted interactions
made by our SVM matched a significant number of
known protein-protein interactions and were enriched in
known and novel biological processes, suggesting that
many more predictions are likely to be correct.
Methods
Training Data
We trained our predictor using data from mouse protein
microarray and human phage display experiments [7,9].
Interactions were collected in the form of domain-
peptide sequence pairs, where domains were represented
by their binding site and peptides were five residues in
length. For both mouse and human PDZ domains, we
omitted those whose binding site did not align well with
other PDZ domains [16]. Human domains that lacked
adequate data (less than 10 interactions), or were difficult
to generate artificial negative interactions for, were also
n o tu s e d .T h i sl e f t8 2o u to f8 5m o u s ea n d3 1o u to f
54 human PDZ domains. Since phage display data may
contain non-genomic interactions and we were interested
in building a genomic predictor, we filtered the human
phage display data to create a data set enriched in geno-
mic-like interactions. First, an interaction was considered
to be genomic-like if the last four residues of the interact-
ing peptide matched a human protein tail (defined
by genome assembly Ensembl:GRCh37.56), otherwise it
was defined as non genomic-like. Then, domains were
categorized as genomic-like, non genomic-like, dual or
non-specific, depending on the number of unique geno-
mic-like or non genomic-like interacting peptides they
bound to (Table 1). To enrich for genomic-like interac-
t i o n sw ed i dn o tu s ea n yd a t af r o mn o ng e n o m i c - l i k e
domains and removed all non genomic-like interactions
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unique genomic-like peptides after this filtering were not
used. Finally, data from genomic-like and non specific
domains (that had a combined total of ≥10 peptides)
were used without any filtering. This resulted in a small
number of non genomic-like interactions being included,
but allowed us to increase the amount of phage display
data usable for training. In total, data for 20 human and
82 mouse domains were used for training (Table 2).
Please see additional file 1: Supplementary Information
for more details about how the data sets were created.
Artificial negative interactions for phage display
Since we considered the prediction of PDZ domain inter-
actions as a binary problem (i.e. binds or does not bind),
training an effective predictor required both positive and
negative interaction data. We generated artificial negative
interactions for the human phage display data since they
only contained positive interactions. Based on previous
research the proper selection of artificial negatives is
important for successful predictor training and evalua-
tion [18,19]. Random and shuffled peptide sequences
have been commonly used, but since these negatives do
not resemble real sequences, they have been shown to
produce predictors with lower accuracy when predicting
real negative interactions [19]. We generated artificial
negative interactions for training based on positive inter-
actors (peptide ligands) modelled using PWMs. There-
fore a PWM for a given PDZ domain was used to select
likely negative interactors for that domain from a set of
unique real interactors for all domains. For a given
domain, negative interactors are those peptides with low
PWM scores and low redundancy with other selected
peptides. We set the score cut off to be the minimum
score among all the PWM scores computed for the posi-
tive interactors (see additional file 1: Supplementary
Information for more details). For the 20 human phage
display domains, a total of 745 artificial negative interac-
tions were generated (Table 2). The number of positive
and negative training interactions was balanced using a
weighted cost support vector machine.
Primary sequence based feature encoding
Each domain-peptide sequence pair was encoded as a
vector of numeric values representing features of a posi-
tive or negative interaction. Values were scaled to lie
between 0 and 1 [20]. We used the ‘contact map’ encod-
ing method described in Chen et al. A contact map con-
tains information about contacting residues in the
domain binding site and peptide derived from a protein
structure of a PDZ domain complexed with a peptide
ligand [16]. In total, 16 domain binding site positions
found to be in contact (< 5.0 angstroms) with the last five
peptide positions were used, based on the 3D structure of
mouse a1-syntrophin in complex with a heptapeptide.
This corresponded to 38 contacting domain and peptide
position pairs. Each amino acid residue pair was numeri-
cally encoded as a binary vector of length 400 represent-
ing a 20 × 20 binary matrix to capture all possible amino
acid pairs. The final encoding consisted of a binary vector
of size 15200 (38 × 400). Contact maps for other domains
were constructed via a multiple sequence alignment [16].
Support vector machine
A support vector machine is a machine learning method
that makes binary predictions [21,22]. Given interaction
training data (x1,y1),...,(xm,ym)w h e r exi is a feature vector
for domain di and peptide pi and y is a class label such
that yi = {-1, +1}, a binary predictor assigns a class label
of +1 if a given interaction feature vector encodes a posi-
tive interaction or -1 otherwise. SVMs evaluate the fol-
lowing decision function to make binary predictions:
fw b xx () =• + () sgn
where sgn(0) = +1, otherwise -1. The margin w and
bias term b describe a maximum margin hyperplane
separating positive and negative training points and are
solutions to the following optimization problem:
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Table 1 Domain category definitions based on the
number of unique interacting genomic-like and non
genomic-like peptides
Category # Unique genomic-like
peptides
# Unique non genomic-like
peptides
Genomic-like ≥10 <10
Non
genomic-like
<10 ≥10
Dual ≥10 ≥10
Non specific <10 <10
Table 2 Summary of the training data
Domains Interactions
Organism Source # Pos # Neg # Pos # Neg
Mouse Protein microarray 82 72 643 1324
Human Phage display 20 - 363 -
Human Artificial negatives - 20 - 745
Total 102 92 1006 2069
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Page 3 of 13where K (xi,x j) can be regarded as describing the
similarity between two feature vectors, a’s are Lagrange
Multipliers and C is a cost parameter that penalizes
training errors. The radial basis function (RBF) kernel
was used here and is defined as:
Ke ij
ij xx
xx ,
|| || () =
−− 
2
Locally optimal values for g and C were determined
using grid search. We used weighted costs according to
C
+ =( n
+/n
-)C
-,w h e r en
+ is the number of positive
training interactions and n
- is the number of negative
training interactions. LibSVM was used to build the
SVM [23].
Predictor performance evaluation
Multiple cross validation strategies were used to
estimate the SVM’s ability to extrapolate to unseen
interaction data. We used 10 fold cross validation by
partitioning the training data into 10 randomly selected
interaction sets, independently holding out each set for
testing against a predictor trained using the remainder
of the data, and averaging the performance across all 10
runs. For comparison purposes, we also followed the
procedure of Chen et al. [16], to estimate the predictor’s
ability to generalize to different unseen data by holding
out 8% of the domains, 12% of the peptides and both
8% of the domains and 12% of the peptides and testing
on the rest, again repeated 10 times.
We compared different predictors, through testing
using independent genomic data sets in worm, fly,
mouse and human collected from different sources
(Table 3). In particular, we used data from Chen et al.
[16], which included interactions from protein microar-
ray experiments for fly, worm and mouse orphan
domains. Mouse orphan domains were those from the
original mouse protein microarray experiment that did
not interact with any of the peptides tested. In Chen et
al., a subset of interactions involving these domains
were retested using fluorescence polarization to identify
false negatives which were then corrected to be positive
interactions [16]. We also used known human interac-
tion data from PDZBase [17].
We computed the following statistics to measure pre-
dictor performance:
￿ True positive rate (TPR) or Recall: #TP/#P
￿ False positive rate (FPR): #FP/#N
￿ Precision: #TP/(#TP + #FP)
￿ F1 Measure: 2 (Precision × Recall)/(Precision +
Recall)
where #TP is the number of true positives, #P is the
number of positives, #FP is the number of false posi-
tives, #N is the number of negatives. The overall perfor-
mance was summarized by computing the area under
the ROC and PR curves (AUCs) [24,25].
Results
Estimating support vector machine performance
The SVM achieved high AUC scores from multiple
cross validation testing. The highest ROC and PR AUCs
of 0.939 and 0.896 respectively were obtained when 10%
of interactions were held out for testing. For tests that
involved holding out all interactions for a given domain,
the AUC scores were lower. In particular, the leave 12%
of domains out test yielded ROC and PR AUC scores of
0.851 and 0.764 and the leave 12% domain and 8% pep-
tides out yielded ROC and PR AUC scores of 0.87 and
0.794 (Figure 1). In contrast, the leave 8% peptides out
yielded higher ROC and PR AUCs of 0.893 and 0.838.
This suggests that the SVM’s ability to accurately pre-
dict a given test domain depends on its level of similar-
ity to the training domains. To determine the degree of
this dependency we performed leave one domain out
cross validation and divided the AUC scores according
to the binding site similarity of the held out domain to
that of its nearest training neighbour. We repeated this
using a simple nearest neighbour predictor (NN) and
compared the results. The results showed that, indeed,
the SVM achieves a higher performance for domains
that are more similar to the training set. The SVM was
on average better than the nearest neighbour method
for testing domains with over 60% sequence similarity
to their nearest training neighbour (Figure 2 top). Pre-
sumably, this means the SVM learned non-trivial pat-
terns in the data features instead of simply indentifying
similarities in the sequences as the NN predictor did.
For tested peptides, this dependence was not as appar-
ent, which indicates that the SVM’s performance is
more dependent on domain sequence similarity than
peptide sequence similarity (Figure 2 bottom). For more
details about nearest neighbour predictor see additional
file 1: Supplementary Information.
Table 3 Summary of data for independent genomic
testing and prediction validation
Domains Interactions
Organism Source # Pos # Neg # Pos # Neg
Fly Protein microarray 7 7 34 106
Worm Protein microarray 6 6 59 88
Mouse (Orphan) Protein microarray 11 19 52 74
Human PDZBase 13 - 38 -
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across organisms
We next validated our choice of data and methods for
three major parameters affecting predictor performance:
training data, feature encoding and artificial negatives.
We examined each parameter independently by compar-
ing our SVM to other SVMs built using different values
for the parameter of interest while holding the other
two parameter values fixed. Predictor performance was
assessed using data for mouse, worm and fly from inde-
pendent protein microarray experiments, which all con-
tain positive and negative interactions [16].
Genomic-like phage display training data
We first validated our use of mouse protein microarray
and human genomic-like phage display data for training.
We compared our SVM to those built using data from
single experimental data types (mouse/protein microar-
ray or human/phage display), both experimental data
types (mouse/protein microarray and human/phage dis-
play) and both experimental data types but with human
phage display data enriched in genomic-like or non
genomic-like interactions. For all SVMs, contact map
features were used to encode the data and PWMs were
used to generate artificial negatives. A comparison of
predictor performance showed that our SVM was better
than the other predictors for the worm and fly tests
(Figure 3). All predictors had lower scores for the
mouse orphan test. To explain the latter observation, for
each test we computed the binding site similarity of
each testing domain to its nearest training neighbour.
We found that the mouse orphan domains were on
average 65% similar to their nearest training neighbours,
while the worm and fly testing domains were on average
80% and 87% similar to their nearest training neigh-
bours respectively. Therefore the observed pattern of
performance was consistent with our earlier observation
that predictor performance decreased as the similarity
between testing domains to their nearest training neigh-
bours decreased. These results validate our use of both
mouse protein microarray and human genomic-like
phage display interactions for SVM training.
Contact map feature encoding
We next validated our choice of using the contact map
feature encoding. We compared our SVM to those built
using binary sequence or physicochemical property-
based encodings. All predictors used mouse protein
microarray and human genomic-like training data and
PWMs to generate artificial negatives. For the binary
sequence encoding, binary vectors were created using a
vector of length 20 with each element representing an
amino acid and initially set to zero. A single residue was
represented by placing a one in the position represent-
ing that residue. A binary vector was created for each
residue in a domain-peptide interaction pair, with the
final vector of length 20 aa × (length of domain binding
site sequence + length of the peptide sequence). For
physicochemical features, a vector of five real numbers
describing over 500 different physicochemical properties
for each amino acid residue was created for a domain-
peptide interaction sequence [26]. Thus, final vectors
were of length 5 × (length of the domain binding site
sequence + length of the peptide sequence). The predic-
tor performance comparison showed that except for the
mouse orphan test, our SVM had the highest scores
Figure 1 SVM performance estimation using cross validation. SVM performance measured using 10 fold (red), leave 12% of domains out
(blue), leave 8% of peptides out (green), leave 12% of domains and 8% of peptides out (black) cross validation.
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the mouse orphan test to the dissimilarity of the test
domains to the training domains. Those predictors with
better mouse orphan test performance did not general-
ize to the worm or fly tests, supporting the conclusion
that the mouse test is not ideal. These results indicate
that the contact map feature encoding for SVM training
is better compared to binary and physicochemical prop-
erty based encodings.
PWM selected negative interactions for phage
display data
Finally, we validated the use of PWMs for generating
artificial negatives for the phage display training data.
We compared our SVM to those built using random,
shuffled, and randomly selected artificial negatives. All
predictors used mouse protein microarray and human
genomic-enriched phage display training data encoded
using contact map features. Random negatives were cre-
ated using random residues concatenated into peptides
of length five. Shuffled negatives were created by shuf-
fling residues in the positive peptides. Randomly
selected negatives were created by randomly selecting
peptides from the same set of peptides used to select
negatives in the PWM method. We created 100 different
artificial negative data sets from the phage display data
and measured the mean predictor performance. Over all
the tests, the average SVM ROC and PR AUC scores
were 0.71 and 0.60, respectively, which were slightly
higher than the over all average ROC and PR scores for
the other predictors (Figure 3). Specifically, the average
ROC and PR scores were 0.70 and 0.58 for random
negatives, 0.70 and 0.59 for shuffled negatives and 0.69
and 0.58 for randomly selected negatives. Although the
Figure 2 SVM performance dependence on testing and nearest training neighbour sequence similarity. Using leave one domain out
cross validation (top), domain specific ROC and Precision/Recall AUC scores for SVM (blue) and nearest neighbour predictor (black) were
grouped according to a given testing domain’s similarity to its nearest training neighbour. The same was done for peptides using leave one
peptide out cross validation (bottom). The similarity between two domains was calculated as the percentage of matched residues between their
binding site sequences. The similarity between two peptides was calculated as the percentage of matched residues. Numbers in parentheses
indicate the number of domains or peptides in each boxplot.
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Page 6 of 13Figure 3 Comparison of independent genomic test performance of different SVMs. Blue × denotes data or method used by our SVM in all
panels. (Top Row) A comparison of SVMs trained using data from one experiment: mouse from Chen et al. (magenta) or human from Tonikian
et al. (light blue), from two experiments: mouse and human (green) and from two experiments with data enriched in genomic-like or non
genomic-like human data: mouse and genomic-like human (blue) and mouse and non genomic-like human (red). (Middle Row) A comparison of
SVMs trained using data encoded using different feature encodings: binary sequences (red), physicochemical properties (green), contact map
(blue). (Bottom Row) A comparison of SVMs trained using different methods for generating artificial negatives for phage display: random
peptides (red), shuffled peptides (green), randomly selected peptides (magenta), PWM selected peptides (blue). One hundred different SVMs
trained using different random, shuffled and randomly selected peptides were built.
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the average ROC and PR scores for mouse, worm and
fly tests showed that all predictors performed poorly for
the mouse orphan test but were better for the worm
test. For the fly test however the predictor using PWM
negatives was in general better. This suggests that the
PWM negatives are a reasonable choice for artificial
training negatives with its importance for improving
predictor performance more evident in cases where the
testing domain is highly similar to the training domains.
SVM prediction of PDZ domain interactions by proteome
scanning
We used the SVM to scan the human proteome
(defined by genome assembly Ensembl:GRCh37.56) [27]
to predict binders for 13 human PDZ domains with
available validation data in PDZBase. In total, 41,193
unique transcript tails of length five, out of 77,748
transcripts corresponding to 23,675 genes from the
human proteome, were scanned. We also scanned the
worm and fly proteomes (defined respectively by gen-
ome assemblies Ensembl:WS200.56 and Ensembl:
BDGP5.13.56) [27] for binders for six and seven PDZ
domains respectively, with known genomic interactions
from Chen et al. [16]. For worm, 19,864 unique tran-
script tails of length five, out of 27,533 transcripts corre-
sponding to 20,158 genes, were scanned. For fly, 14,691
unique transcript tails of length five, out of 21,309 tran-
scripts corresponding to 20,158 genes, were scanned. In
all cases, very few known genomic interactions (on aver-
age 2.2 human, 4.2 worm and 9.8 fly) were available
for validation of the domains tested making accurate
assessment of predictor performance difficult. Nonethe-
less, the results reported here serve as a reasonable per-
formance estimate. SVM predictions are available at
http://baderlab.org/Data/PDZProteomeScanning.
For human, over 85% of PDZBase interactions for 10
of the 13 human domains were predicted by the SVM.
Of the three remaining domains, MAGI2-2 and
MAGI3-1 had no PDZBase interactions correctly
predicted, but these domains had only one known
interaction each. Two other domains (PDZK1-1 and
SNTG1-1) also had only one known interaction each
however the SVM correctly predicted the single interac-
tion for these domains. Further experimental validation
and more detailed literature searches should be carried
out to obtain a more reliable assessment of SVM per-
formance for these domains. For the last domain
(MLLT-4), only one out of six known interactions was
predicted, however compared to the other domains
tested, this domain was the most dissimilar to its near-
est training neighbour with a similarity of 0.68. It also
had no homologs in the training data making it a chal-
lenging test case.
For worm and fly, 25% and 37% of protein microarray
interactions respectively were predicted. Although this is
much lower than the human proteome scanning result,
the false positive rates are both quite low at approxi-
mately 4%. In particular, in worm and fly, none of the
known interactions were predicted for DSH-1 despite it
having a reasonable number of known interactions
(11 and 3 respectively) and being very similar to its
nearest training neighbour (over 0.8). In fly, the SVM
did not make any predictions for PAR6-1 even though it
too was very similar to its nearest training neighbour
(1.0). Through further analysis, we found that in each
case, the nearest training neighbours DSH-1 and
PAR6B-1 in mouse had only three and two training
interactions respectively. This suggests the possibility
that predictor performance might also depend on the
abundance of nearest neighbour training data. However,
a single exception to this is that the SVM did not pre-
dict any known interactions for PATJ-2, which had a
reasonable amount of validation data (7 interactions)
and was very similar to its nearest training neighbour
(over 0.81), which also had adequate data (16 interac-
tions). Thus, in general, the SVM is more likely to cor-
rectly predict interactions for domains that are well
represented in the training data in terms of sequence
similarity and interaction abundance.
Comparison of predicted and experimental binding
specificities
Since known interactions are limited, we compared the
predicted and experimental binding specificities to deter-
mine if the set of SVM predictions was consistent with
their corresponding set of experimental binders, at a high
level. Four of the human domains had adequate geno-
mic-like binders from phage display experiments (10 or
more), which were used to create PWMs to summarize
their binding specificities. These were then graphically
represented as sequence logos. For worm and fly, PWMs
were created for five and three domains, respectively,
that had five or more binders determined from protein
microarray experiments. We then created PWMs using
the corresponding predicted binders and computed the
similarity between the predicted and experimentally
determined binding specificities. The average PWM simi-
larity was 67% and the predicted binding specificities cor-
responded to known PDZ domain binding classes I and II
(Figure 4). Two domains (DSH-1 from worm, PATJ-2
from fly) had binding specificity similarities much lower
than the average (less than 60%), however these results
were not unexpected, given the poor results for these two
domains shown above.
Although the experimental and predicted binding
specificities were generally consistent, there were some
discrepancies. For example the human phage display
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V at p0 while this preference is not as strong for the
predicted sequence logos. This is because phage display
experiments only find optimal binders. However, such
binders may not exist in the proteome, leading to the
domain preferring a less optimal binder. This may be
biologically advantageous as weak binders may allow for
easier interaction regulation. To determine whether this
was the case in our data, we scanned the human pro-
teome with the optimal phage display PWMs and cre-
ated genomic sequence logos with the top 1% of
binders. The predicted sequence logos were all more
similar to the genomic phage display sequences logos
than they were to the optimal phage display sequence
logos (see additional file 1: Supplementary Information
Figure S2). Therefore, some discrepancies between
experiment and predicted logos are not unexpected.
Overall, these results show that the SVM predicted
binding specificities are generally consistent with those
that are experimentally determined.
Protein-protein interaction support for predicted
interactions
To provide additional support for our predictions, we
calculated how many corresponded to known protein-
protein interactions (PPIs). Specifically, we scanned the
human proteome for potential binders for 213 human
PDZ domains with known PPIs in the iRefIndex [28],
which is a database integrating PPIs from different
d a t a b a s e si n c l u d i n gB I N D ,B i o G R I D ,C O R U M ,D I P ,
H P R D ,I n t A c t ,M I N T .I ft h ep r o t e i nc o n t a i n i n gt h e
given domain was found to interact with another pro-
tein whose C terminal tail matched the predicted binder,
the prediction was considered to correspond to a known
PPI. The SVM successfully predicted interactions corre-
sponding to known PPIs for 75 of the 213 PDZ domains
with an average of 19% of known PPIs successfully pre-
dicted per domain (see additional file 1: Supplementary
Information Table S9). The number of PPIs successfully
predicted per domain was significant (p < 0.05) for all
but 19 domains. Significance testing was performed
using Fisher’s exact test, which asked whether the
observed number of PPIs predicted for a given domain
could be achieved at random. Since PDZ domain con-
taining proteins may contain multiple PDZ domains, it
is not possible to uniquely assign a PPI to a PDZ
domain. This could result in erroneous false negative or
true positive statistics for the above tests, thus they
should be regarded as a rough estimate of predictor
performance. There were not enough PPI data in iRefIn-
dex to carry out the same analysis for worm and
fly domains. SVM predictions are available at http://
baderlab.org/Data/PDZProteomeScanning.
SVM performance compared to published predictors
Cross validation and a series of independent tests show
that our SVM can accurately predict PDZ domain-
peptide interactions, however, a major issue with most
Figure 4 Comparison of SVM predicted and experimental binding specificities. A comparison of phage display determined and predicted
PDZ domain binding specificities for the last five terminal binding positions visualized as sequence logos. For human, only domains with 10 or
more peptides from phage display experiments by Tonikian et al. were compared. For worm and fly, domains with an adequate (five or more)
number of peptides from protein microarray experiments by Chen et al. were compared.
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too many false positives. We thus compared the pro-
teome scanning performance of our SVM and published
prediction methods - the multidomain selectivity model
(MDSM) by Stiffler et al. and the additive model by
Chen et al. which are both state-of-the art and trained
using mouse protein microarray data in their original
publications [9,16]. We also developed an ensemble of
PWMs, one per domain, built using the same data used
to train the SVM. The PWM corresponding to the near-
est training neighbour for a given test domain, as mea-
sured by binding site similarity, was then used to scan
the proteome for the top 1% of PWM scoring binders.
This predictor represented our baseline for comparison.
We used the F1 measure to compare predictor perfor-
mance since it summarizes the precision/recall perfor-
mance of a predictor and is used in document retrieval
where the recovery of relevant documents from a large
number of possibilities is critical. For all predictors, the
majority of F1 measures are low (less than 0.1). This is
likely due to the high level of incompleteness in the
benchmark used to validate the predictions. However,
the results show that the SVM achieves a higher average
F1 measure (0.037) than the other predictors demon-
strating its improved accuracy and precision. In com-
parison, the average F1 measures were 0.02, 0.005
and 0.016 for the MDSM, additive model and PWM
predictor respectively. For fly and worm domains, we
computed the false positive rate and found it to be
approximately 4% and substantially (over 4 times) lower
than the FPRs of the other predictors (Figure 5).
The performance of the MDSM and SVM was close
and the SVM’s improved performance may be due to its
use of a larger training data set (both phage display and
microarray). To more directly compare these two pre-
dictors, we trained an SVM with only mouse microarray
data and compared the performance. The results show
that no predictor method is clearly better than the
other. The MDSM’s performance is not consistent as
shown by the fly test results, which has similar testing
and training data sets, and is expected to be an easy test
(see additional file 1: Supplementary Information Figure
S3 left). On the other hand, the performance of the
SVM trained only using microarray data is more consis-
tent, but has a higher false positive rate compared to
the MDSM (see additional file 1: Supplementary Infor-
mation Figure S3 right). These results suggest that our
predictor performance improvement is likely due to our
u s eo fm o r et r a i n i n gd a t a .I tm a yb ep o s s i b l et om o d i f y
the MDSM method to accept phage display data as
training, though the SVM method naturally accepts this
data without method modification - a clear advantage in
terms of flexibility. Overall, these results demonstrate
the SVM’s improved performance over other published
predictors for proteome scanning of PDZ domain inter-
actions. For more details about the predictors used for
comparison please see additional file 1: Supplementary
Information.
Furthering our understanding of PDZ domains and the
biological processes they mediate
To demonstrate how our predictions can be used to
further our understanding of PDZ domains and the bio-
logical processes they mediate, we performed GO biolo-
gical process term enrichment analysis of the predicted
binders using the BiNGO (Biological Network Gene
Ontology tool) software library [29]. The hypergeometric
test was used to compute a p-value assessing the GO
term enrichment for a given set of predicted genes.
Multiple testing correction was performed using the
Benjamini and Hochberg False Discovery Rate (FDR)
correction. While we did not have enough information
to perform the analysis with worm and fly, almost all
human PDZ domain binder lists were statistically
enriched (p < 0.05) for known PDZ domain processes
such as ion transport and localization (see additional
file 1: Supplementary Information Table S10). Interest-
ingly, the biological process ‘photoreceptor cell mainte-
nance’ was found enriched only among the predicted
genes for the PDZ domain containing protein PDZK1-1.
These genes include those that encode proteins asso-
ciated with Usher (USH1G, USH2A) and Bardet-Biedl
syndromes (BBS10); both are genetic human diseases of
the cilia with wide ranging symptoms including retinal
degeneration [30]. Although disruption of PDZ mediated
interactions are known for Usher syndrome, such a dis-
ruption involving PDZK1-1 has not been reported for
either. Since the validity of our predicted binders is sup-
ported by the successful prediction of known interac-
tions in PDZBase and iRefIndex (1 out of 1 and 4 out of
24 respectively), with experimental validation, these
potential PDZ domain mediated interactions may pro-
vide further insight into the molecular mechanisms
underlying Usher and Bardet-Biedl syndromes.
Discussion
We have presented a predictor, which can be used to
more accurately and precisely scan proteomes of organ-
isms for potential binders of PDZ domains. We focused
on the application of proteome scanning. The results of
our predictor can help prioritize biological experiments.
In addition, since our predictions are predicted in vitro
interactions, they can also be used as input to computa-
tional methods aiming to predict likely in vivo interac-
tions by including multiple lines of evidence, such as
co-expression and binding site conservation [31,32]. In
both cases our predictions will be useful for substantially
reducing the number of candidates that need to be
Hui and Bader BMC Bioinformatics 2010, 11:507
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of our proteome scanning results we also expect the
predictor to perform well in organisms which are closely
related to human, worm and fly.
An interesting result from our work is that binding site
sequence information at contacting positions in the
domain was the most effective feature encoding method
among the ones we tried. The poor performance obtained
by the other encoding methods (flatly representing binary
sequence or physicochemical properties) suggest that by
explicitly encoding contacting domain and peptide posi-
tion pairs, sequence information need only be used to
obtain good predictor performance. While we showed that
this results in a predictor that relies to some degree on
binding site sequence similarity, we also showed that this
dependence only exists for the domain and not the pep-
tide. We established a sequence similarity threshold of
60% for testing domains, which may act as a rough indica-
tor of the limits of our predictor and can be used identify
poorly characterized PDZ domains in current data sets.
The use of PWMs to generate artificial negatives was
motivated by previous work that showed the importance
of training with artificial negatives, which resemble real
negative interactions. In one study, predictors were
trained using random and shuffled negatives to show
that this resulted in predictors with lower accuracy
when real sequences were used for testing [18,19]. In
other work, artificial negatives were generated by pairing
proteins with different co localizations or randomly pair-
ing proteins known to not interact. It was shown that
this created a constraint on the distribution of the nega-
tives making it easier for the predictor to distinguish
between positive and negative interactions. This led to
biased estimates of predictor performance when cross
validation was used [18]. Since our PWM negatives
were selected from peptides involved in real positive
interactions, they are biological sequences and we expect
their distribution to be closer to biologically meaningful
interactions. We also believe that this results in a more
realistic learning problem for the predictor and may
reduce the bias in predictor accuracy estimation and
benefit predictor performance in practice. However, we
realize that PWMs may have high false positive rates
due to limitations such as their inability to model
dependencies between ligand positions. These shortcom-
ings may be responsible for the modest improvement in
independent testing performance between predictors
trained using PWM generated and other negatives.
Although many of our proteome scanning predictions
were validated using known interactions, the lack of a
complete benchmark of genomic PDZ domain interac-
tions contributes to our low F1 measures (most are less
than 0.1). This may be addressed to some degree by
using more validation data from experiments or literature
Figure 5 Comparison of proteome scanning performances for SVM and published predictors. A comparison of predictor performance
evaluated using F1 measures and FPRs for 13 human (blue), 6 worm (green) and 7 fly (black) PDZ domains. Three different predictors were
compared: MDSM, additive model and a PWM predictor. PDZBase interactions were used to validate human predictions. Protein microarray
interactions from Chen et al. were used to validate fly and worm predictions. The median is denoted by the red circle. No FPRs were
calculated for human predictions since there are no negative human validation interaction data. MDSM and the additive model were trained
in their original publications using mouse protein microarray data only. The PWM predictor was trained using the same mouse and human
data as the SVM.
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of the F1 and FPR measurements. In the case of two fly
domains LAP4-2 and LAP4-3, the SVM did achieve
higher F1 measures of 0.17 and 0.25 respectively. The
SVM predicted many known interactions but also pre-
dicted a very small number of fly proteins as potential
binders (34 and 8 respectively). In general, the SVM
made far less positive predictions than the other predic-
tors, which raises the question of whether the SVM is
simply more conservative (by making fewer predictions)
or actually more precise (by making fewer and more
accurate predictions) compared to other predictors.
Again, this cannot be fully answered without more vali-
dation data, however the SVM’s higher F1 and lower FPR
scores are strong evidence supporting the latter case.
In genomic tests, predictor performance was consis-
tently poor for the mouse orphan test, which consisted of
domains that were highly dissimilar to the training
domains. Based on our finding that predictor perfor-
m a n c ed e p e n d so nt h es i m i l a r i t yb e t w e e nt e s t i n ga n d
training domains, this result was not unexpected. How-
ever, even if the similarity between testing and training
domains is similar, predictor performance can still be
poor. This was discovered while scanning the fly pro-
teome for binders of PATJ-2. We found that the nearest
training neighbour for this domain according to binding
site sequence similarity did not correspond to its known
human homolog, which was present in the training data.
This highlighted a limitation generally faced by sequence
based predictors: if the training domains best represent-
ing a given testing domain do not share similar sequence
features, the correct binding specificity may not be prop-
erly learned. This may occur for two domains with struc-
turally or physicochemically similar binding sites
encoded with very different amino acid sequences. This
may be the reason for the SVM’s inability to predict any
known interactions for PATJ-2. Exploring structural
domain features useful for SVM training may determine
if this is the case.
While our SVM performs better than published meth-
ods on proteome scanning, it can clearly be improved.
One way to do this is to consider additional relevant
features, such as information related to protein struc-
ture. For example, it has been shown that entropic and
thermodynamic features of PDZ domain binding can
vary considerably across PDZ domains and even for the
same PDZ domain bound to different ligands [33,34].
Therefore, including dynamic features such as electro-
static or non-polar contributions between contacting
residues may be used to help improve SVM perfor-
mance. Another approach would be to use an SVM with
a structure based kernel for PDZ domains. Indeed,
recent work showed that an SVM using a structure
based kernel was successful in the more general
problem of predicting protein-protein interactions [35].
The main challenge for both these approaches is that
3D structures are not availab l ef o rt h em a j o r i t yo fP D Z
domains and homology modelling would be needed to
increase the number of domains available for training
and testing. A structure-based approach may also be
used to generate more accurate biologically meaningful
artificial negatives for training. Thus, until larger train-
ing datasets are available, we may require a combination
of strategies to predict PDZ domain interactions, invol-
ving both sequence and structure-based methods, to
maximize coverage and prediction performance. None-
theless, here we have shown that sequence similarity is
an important feature for accurately predicting PDZ
domain interactions and it will be interesting to see how
general this feature is for other domains.
Conclusions
We describe a SVM for the prediction of genomic PDZ
domain interactions. Our method uses training data
from two independent high throughput experiments
from mouse and human, for the first time, which
improves performance. We showed that compared to
published state-of-the-art predictors, our predictor can
be used to more accurately and precisely scan pro-
teomes for potential binders of PDZ domains. These
predictions can be used to increase the accuracy and
coverage of PDZ domain interaction networks and
further our understanding of the roles that PDZ
domains play in a variety of biological processes. Ideally,
we would construct predictors like this one for all pep-
tide recognition domains and use them to help map
protein interactions in the cell.
Availability and Requirements
Project name: PDZ Proteome Scanning
Project home page: http://baderlab.org/Data/
PDZProteomeScanning
Operating systems: Platform independent
Programming language: Java 1.5
License: Source code is freely available under the
GNU Lesser Public General License (LPGL).
Additional material
Additional file 1: Supplementary Information. HuiBader2010-BMC-
SupplementaryInfo.pdf. This file contains more details about the data and
methods discussed in this paper.
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